Helix BioPharma Corp.

(HBP:CA)

By |

Profile

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.

Contact Information

Website: www.helixbiopharma.com
Email: helix@helixbiopharma.com
Main Phone: +1 905 841-2300
Address: 9120 Leslie Street
Address 2: Suite 205
State: ON
City / Town: Richmond Hill
Country: CA
Postal Code: L4B 3J9

Issuer Information

Exchange: TSX
CEO: Heman Chao
Employees: 11
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.

Contact Information

Website: www.helixbiopharma.com
Email: helix@helixbiopharma.com
Main Phone: +1 905 841-2300
Address: 9120 Leslie Street
Address 2: Suite 205
State: ON
City / Town: Richmond Hill
Country: CA
Postal Code: L4B 3J9

Issuer Information

Exchange: TSX
CEO: Heman Chao
Employees: 11
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.85 $ -0.03 (-3.41%)
Last Price 0.85 Change $ -0.03 Change % -3.41 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.92 High 0.93 Low 0.85 Prev Close 0.88
Last Trade Volume 28,390 52 Wk Hi 2.01 52 Wk Low 0.25
Market Cap 120 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 141,133,017.00 EPS (TTM) -0.06 PE Ratio -14.70 Exchange TSX
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1